Q2 2019 13F Holders as of 30 Jun 2019
-
Type / Class
-
Equity / S&P BIOTECH
-
Total 13F shares
-
66,459,439
-
Share change
-
-6,326,841
-
Total reported value
-
$5,822,066,803
-
Put/Call ratio
-
220%
-
Price per share
-
$87.71
-
Number of holders
-
422
-
Value change
-
-$555,668,077
-
Number of buys
-
173
-
Number of sells
-
198
Institutional Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2019
As of 30 Jun 2019,
SPDR SERIES TRUST - S&P BIOTECH (XBI) was held by
422 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
66,459,439 shares.
The largest 10 holders included
MORGAN STANLEY, BNP PARIBAS ARBITRAGE, SA, CITIGROUP INC, GOLDMAN SACHS GROUP INC, UBS Group AG, JPMORGAN CHASE & CO, BANK OF AMERICA CORP /DE/, BARCLAYS PLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, and TWO SIGMA ADVISERS, LP.
This page lists
422
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.